150
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Novel model of double transgenic mouse results in autoimmune diabetes in males

, , &
Pages 397-404 | Received 13 Jan 2016, Accepted 06 Jun 2016, Published online: 11 Aug 2016
 

Abstract

Identifying the type of diabetogenic CD8+ T cells that initiate autoimmune diabetes (AID) is a critical step in designing appropriate strategies for the early detection of beta cell-directed autoimmunity and its progression to diabetes. We generated a novel double transgenic (Tg) mouse model on the naturally diabetes resistant C57Bl/6 background, co-expressing two transgenes including a specific TCR anti-lymphocytic choriomeningitis virus nucleoprotein (LCMV-NP) carried by CD8+ T cells and LCMV-NP (as neo-self antigen) expressed by pancreatic beta cells. The resulting double Tg mouse showed partial thymic deletion of the NP-specific CD8+ T cells. The escaping autoreactive NP-specific CD8+ T cells joining the periphery were activated and gained effector functions. Both male and female mice mounted anti-NP antibodies, but only one-fourth adult males spontaneously developed AID. Significant upregulation of the CD44 and CD122 markers as compared to healthy male and female mice characterized the phenotype of diabetogenic CD8+ T cells in diabetic male mice. We also show that only 10% of these CD8+  T cells expressed programmed death 1 receptor (PD-1). Together, these results suggest that in our double Tg mouse model, Ag-specific effector CD44+CD122+PD-1CD8+ T cell subpopulation is associated with the pathogenesis of AID.

Acknowledgements

We would like to acknowledge A. Lamarre (INRS-Institut Armand-Frappier, Laval, QC, Canada) for having kindly provided the Dd-NP396–404 tetramer.

Declaration of interest

The authors declare no conflicts of interest. This work was supported by grants from Research Center of CHU Ste-Justine (to I.D.S.) and Ste-Justine Foundation scholarship (to S.C.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.